Literature DB >> 19275883

Gene expression and cell growth are modified by silencing SUMO2 and SUMO3 expression.

Wei Yang1, Wulf Paschen.   

Abstract

Small ubiquitin-like modifier (SUMO) is a group of proteins binding to lysine residues of target proteins and thereby modifying their stability, activity and subcellular localization. Here we report that blocking SUMO2 and SUMO3 conjugation by silencing their expression markedly modifies gene expression. A microRNA-based RNAi system was used to specifically silence SUMO2 and SUMO3 expression simultaneously and stably transfected neuroblastoma B35 cells expressing dual SUMO2/3 microRNA were created. In cells stably expressing SUMO2/3 microRNA, mRNA levels of 105 and 58 known genes were significantly up- and down-regulated, respectively. About 20% of differentially regulated genes were associated with pathways involved in cell growth and differentiation. Cell division was significantly suppressed in SUMO2/3 miRNA expressing cells. Elucidating what effect the silencing of SUMO2/3 expression has on gene expression will help to identify the impact of SUMO2/3 conjugation on the various cellular pathways.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19275883     DOI: 10.1016/j.bbrc.2009.03.013

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

1.  Modification of human papillomavirus minor capsid protein L2 by sumoylation.

Authors:  Martina Bergant Marusic; Nina Mencin; Mia Licen; Lawrence Banks; Helena Sterlinko Grm
Journal:  J Virol       Date:  2010-08-25       Impact factor: 5.103

2.  Analysis of oxygen/glucose-deprivation-induced changes in SUMO3 conjugation using SILAC-based quantitative proteomics.

Authors:  Wei Yang; J Will Thompson; Zhengfeng Wang; Liangli Wang; Huaxin Sheng; Matthew W Foster; M Arthur Moseley; Wulf Paschen
Journal:  J Proteome Res       Date:  2011-12-01       Impact factor: 4.466

3.  Regulation of neuronal morphogenesis by 14-3-3epsilon (Ywhae) via the microtubule binding protein, doublecortin.

Authors:  Brett Cornell; Tomoka Wachi; Vladimir Zhukarev; Kazuhito Toyo-Oka
Journal:  Hum Mol Genet       Date:  2016-10-15       Impact factor: 6.150

4.  Small ubiquitin-like modifier 1-3 conjugation [corrected] is activated in human astrocytic brain tumors and is required for glioblastoma cell survival.

Authors:  Wei Yang; Liangli Wang; Gabriele Roehn; Robert D Pearlstein; Francis Ali-Osman; Hongjie Pan; Roland Goldbrunner; Matthew Krantz; Christoph Harms; Wulf Paschen
Journal:  Cancer Sci       Date:  2012-11-28       Impact factor: 6.716

5.  Neuron-specific Sumo1-3 knockdown in mice impairs episodic and fear memories.

Authors:  Liangli Wang; Ramona M Rodriguiz; William C Wetsel; Huaxin Sheng; Shengli Zhao; Xiaozhi Liu; Wulf Paschen; Wei Yang
Journal:  J Psychiatry Neurosci       Date:  2014-07       Impact factor: 6.186

6.  SUMO2/3 conjugation is an endogenous neuroprotective mechanism.

Authors:  Anna Lena Datwyler; Gisela Lättig-Tünnemann; Wei Yang; Wulf Paschen; Sabrina Lin Lin Lee; Ulrich Dirnagl; Matthias Endres; Christoph Harms
Journal:  J Cereb Blood Flow Metab       Date:  2011-08-24       Impact factor: 6.200

7.  Identification of 10 SUMOylation-Related Genes From Yellow Catfish Pelteobagrus fulvidraco, and Their Transcriptional Responses to Carbohydrate Addition in vivo and in vitro.

Authors:  Shui-Bo Yang; Xiao-Ying Tan; Dian-Guang Zhang; Jie Cheng; Zhi Luo
Journal:  Front Physiol       Date:  2018-11-08       Impact factor: 4.566

8.  Epstein-Barr Virus BGLF2 commandeers RISC to interfere with cellular miRNA function.

Authors:  Ashley M Campbell; Carlos F De La Cruz-Herrera; Edyta Marcon; Jack Greenblatt; Lori Frappier
Journal:  PLoS Pathog       Date:  2022-01-10       Impact factor: 6.823

9.  SUMO-2 promotes mRNA translation by enhancing interaction between eIF4E and eIF4G.

Authors:  Li-zhao Chen; Xiang-yun Li; Hong Huang; Wei Xing; Wei Guo; Jing He; Zhi-ya Sun; An-xiong Luo; Hua-ping Liang; Jing Hu; Zheng-guo Wang; Yun-sheng Xu; Xiang Xu
Journal:  PLoS One       Date:  2014-06-27       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.